Kintor Pharma focuses on developing innovative small molecules and biologic drugs for dermatology and oncology with substantial unmet needs, especially androgen receptor-related diseases. Kintor Pharma's product pipeline consists of six ongoing clinical products, including androgen receptor antagonists, AR-PROTAC, ALK-1 monoclonal antibody, Hedgehog/SMO inhibitor and mTOR inhibitor. The company also has ongoing preclinical programs in ALK-1/VEGF dual-targeting antibody and c-Myc inhibitors. We are actively seeking partnerships for China and worldwide, welcome to contact us!
Tel：+86 512 6263 9916，+86 512 6263 9920
Email：BD@kintor.com.cn
Focus Us
Copyright: Kintor Pharmaceutical Limited retains all copyrights. 苏ICP备19028699号-2 Powered by 300.cn SEO Business License
Complaints and Suggestions Tel: +86 512 62639935 Email: public@kintor.com.cn
Find Us
Copyright: Kintor Pharmaceutical Limited retains all copyrights.
Complaints and Suggestions Tel: +86 512 62639935 Email: pr@kintor.com.cn
Copyright: Kintor Pharmaceutical Limited retains all copyrights.
Powered by 300.cn